New model to explain the role of dopamine in immune regulation described

October 11, 2012

Dopamine is a neurotransmitter that is associated with emotions, movement, and the brain's pleasure and reward system. In the current issue of Advances in Neuroimmune Biology, investigators provide a broad overview of the direct and indirect role of dopamine in modulating the immune system and discuss how recent research has opened up new possibilities for treating diseases such as Parkinson's and Alzheimer's disease, schizophrenia, multiple sclerosis or even the autoimmune disorders.

Dopamine can be synthesized not only in neurons, but also in which orchestrate the body's response to infection or . "Data strongly supports the theory that an autocrine/paracrine regulatory loop exists in lymphocytes, where dopamine produced and released by the cells then acts on its own receptors, and can have an influence on its own function," explains lead investigator György M. Nagy, PhD, DSc, of the Department of Human Morphology, Cellular and Molecular Neuroendocrine Research Laboratory, Hungarian Academy of Sciences, and Semmelweis University, Budapest, Hungary.

Elements of dopamine signaling and metabolites can also serve as a between the and immune system, and that communication can work in both directions. Lymphocytes that can pass the can be "educated" by locally secreted neurotransmitters, including dopamine. Then they transmit brain-driven messages to other cells of the immune system via direct or indirect pathways.

Permanent dysfunctions of either the central (CNS) or the peripheral (immune) are frequently associated with immune malfunctions. Current dopamine replacement or receptor blocking therapies are based on the supposed action of these drugs at the site, and they often only relieve disease symptoms. The mainstream in design of new therapies is to find drugs having more-and-more specific action and minimal or no potential side effects, however, there is always a risk/benefits consideration in the drug development processes. These approaches may need to be revisited with the concepts of neuroimmunomodulatory influence, and focus on the cross-talk between the immune and nervous systems," Dr. Nagy says.

Various immune mechanisms may contribute to the pathogenesis of neurological disorders. The pharmacological design of targeted drug delivery systems could carry a desired compound right to the sites of cellular pathologies, Dr. Nagy observes. "Well designed clinical trials are needed for the critical evaluation of the new theories in human therapy, either by the use of available drugs with extended immunomodulatory functions, or newly designed compounds, or the combination of both. Evaluation of clinical efficacy and data on safety of patients should provide an answer to these questions," he concludes.

In a commentary accompanying the article, Istvan Berczi and Toshihiko Katafuchi, Editors-in-Chief of Advances in Neuroimmune Biology, ask why a central nervous system mediator such as dopamine would be produced locally, when dopamine made centrally could be deployed when necessary. "We suggest that the function of paracrine/autocrine (P/A) circuits is to maintain tissue viability in emergency situations, when no other regulators are available. Local P/A circuits are the key to healing and recovery," they say.

Dr. Berczi and Prof. Katafuchi note that the science of cryobiology, which deals with the medical application of hypothermia and freezing and tissue culture techniques, which grow cells and tissues in vitro from animals and man, owe their existence to P/A circuits to preserve tissue viability and reactivity beyond clinical death or under proper culture conditions. "Clearly, P/A circuits hold the possibility of resurrection after clinical death," they conclude.

Explore further: Therapeutic avenues for Parkinson's investigated at UH

More information: "Role of Peripheral and Brain-Derived Dopamine (DA) in Immune Regulation," by B.E. Tóth, M. Vecsernyés, T. Zelles, K. Kádár, G.M. Nagy. DOI 10.3233/NIB-2012-012044 "Dopamine in Immunoregulation," by I. Berczi, and T. Katafuchi. DOI 10.3233/NIB-2012-012046 Advances in Neuroimmune Biology, Volume 3, Issue 2 (October 2012)

Related Stories

Therapeutic avenues for Parkinson's investigated at UH

August 23, 2012
Scientists at the University of Houston (UH) have discovered what may possibly be a key ingredient in the fight against Parkinson's disease.

Recommended for you

Exposure to larger air particles linked to increased risk of asthma in children

December 15, 2017
Researchers at The Johns Hopkins University report statistical evidence that children exposed to airborne coarse particulate matter—a mix of dust, sand and non-exhaust tailpipe emissions, such as tire rubber—are more ...

Bioengineers imagine the future of vaccines and immunotherapy

December 14, 2017
In the not-too-distant future, nanoparticles delivered to a cancer patient's immune cells might teach the cells to destroy tumors. A flu vaccine might look and feel like applying a small, round Band-Aid to your skin.

Immune cells turn back time to achieve memory

December 13, 2017
Memory T cells earn their name by embodying the memory of the immune system - they help the body remember what infections or vaccines someone has been exposed to. But to become memory T cells, the cells go backwards in time, ...

Steroid study sheds light on long term side effects of medicines

December 13, 2017
Fresh insights into key hormones found in commonly prescribed medicines have been discovered, providing further understanding of the medicines' side effects.

The immune cells that help tumors instead of destroying them

December 12, 2017
Lung cancer is the leading cause of cancer-associated deaths. One of the most promising ways to treat it is by immunotherapy, a strategy that turns the patient's immune system against the tumor. In the past twenty years, ...

Cancer gene plays key role in cystic fibrosis lung infections

December 12, 2017
PTEN is best known as a tumor suppressor, a type of protein that protects cells from growing uncontrollably and becoming cancerous. But according to a new study from Columbia University Medical Center (CUMC), PTEN has a second, ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.